2019
DOI: 10.1158/0008-5472.can-18-2553 View full text |Buy / Rent full text
|
|

Abstract: Pancreatic ductal adenocarcinoma (PDAC) is driven by metabolic changes in pancreatic cells caused by oncogenic mutations and dysregulation of p53. PDAC cell lines and PDAC-derived xenografts grow as a result of altered metabolic pathways, changes in stroma, and autophagy. Selective targeting and inhibition of one of these may open avenues for the development of new therapeutic strategies. In this study, we performed a genome-wide siRNA screen in a PDAC cell line using endogenous autophagy as a readout and iden… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
0
9
0

Publication Types

Select...

Relationship

0
0

Authors

Journals